In lower grade gliomas with IDH mutations and 1p19q co-deletion, the authors found frequent mutations in CIC, FUBP1, PI3 kinase pathway genes, NOTCH1, ZBTB20, and ARIDIA, in addition to activating TERT promoter mutations. The gene discussed is IDH2; the disease is central nervous system cancer.